T Cell Lymphomas
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
From the Journals
American Cancer Society update: ‘It is best not to drink alcohol’
Feature
ASH tackles COVID-19 with hematology-related FAQ, promotes new registries
From the Journals
Lymphocyte, monocyte data can predict treatment response in follicular lymphoma
Blood cell count values at diagnosis can predict the clinical outcomes in follicular lymphoma.
Conference Coverage
Stage I mycosis fungoides is the general dermatologist’s bailiwick
LAHAINA, HAWAII – “Mycosis fungoides is a great masquerader.”
Conference Coverage
CAR T cells produce complete responses in T-cell malignancies
ORLANDO – There were no cases of severe cytokine release syndrome or severe neurotoxicity reported with the anti-CD5 chimeric antigen receptor T...
Conference Coverage
Study halted; ‘hyperprogression’ seen with nivolumab for R/R PTCL
ORLANDO –
Conference Coverage
HDAC/HMA combo shows ‘remarkable’ activity in PTCL
LUGANO, SWITZERLAND – Patients with AITL and PTCL-TFH subtypes had high overall response rates to romidepsin and AZA.
News
Lymphoma risk prompts FDA recall of Allergan’s textured breast implants
The FDA asked Allergan to recall six brands of textured breast implants and expanders because of the lymphoma risk they pose.
Conference Coverage
Creating CAR T-cell therapies for T-cell malignancies
NEWPORT BEACH, CALIF. – Dr. John F. DiPersio discusses preclinical research testing CAR T-cell therapies in T-cell malignancies.
From the Journals
Case report may link gluteal implants to lymphoma
On the heels of increased reports of breast implant–related anaplastic large cell lymphoma, researchers report a case of lymphoma that may be...